{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:26:30Z","timestamp":1773051990075,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Instituto de Salud Carlos III Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Sindrome de Inmunodeficiencia Adquirida","award":["RD016\/0025\/0001"],"award-info":[{"award-number":["RD016\/0025\/0001"]}]},{"name":"Instituto de Salud Carlos III Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Sindrome de Inmunodeficiencia Adquirida","award":["RD12\/0017\/0029"],"award-info":[{"award-number":["RD12\/0017\/0029"]}]},{"name":"Instituto de Salud Carlos III Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Sindrome de Inmunodeficiencia Adquirida","award":["RD16\/0025\/0020"],"award-info":[{"award-number":["RD16\/0025\/0020"]}]},{"name":"Programa Miguel Servet","award":["CPII014\/00025"],"award-info":[{"award-number":["CPII014\/00025"]}]},{"name":"Spanish Ministry of Education","award":["FPU13\/02451"],"award-info":[{"award-number":["FPU13\/02451"]}]},{"name":"Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III FEDER","award":["PI12\/02283"],"award-info":[{"award-number":["PI12\/02283"]}]},{"name":"Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III FEDER","award":["PI16\/00684"],"award-info":[{"award-number":["PI16\/00684"]}]},{"name":"Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III FEDER","award":["FI14\/00431"],"award-info":[{"award-number":["FI14\/00431"]}]},{"name":"Ayudas contrataci\u00f3n de ayudantes de investigaci\u00f3n y t\u00e9cnicos de laboratorio, Consejer\u00eda de Educaci\u00f3n, Juventud y Deporte de la Comunidad de Madrid","award":["PEJ15\/bio\/tl-0064"],"award-info":[{"award-number":["PEJ15\/bio\/tl-0064"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.virusres.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:30:59Z","timestamp":1550230259000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use"],"prefix":"10.1016","volume":"264","author":[{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Ruiz-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Taranc\u00f3n-D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Dronda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Dom\u00ednguez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"P\u00e9rez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-878X","authenticated-orcid":false,"given":"Alejandro","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2019.02.007_bib0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/aid.2010.0263","article-title":"HTLV-2b among HIV-1-coinfected injecting drug users in Spain","volume":"27","author":"Abad","year":"2011","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.007_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/QAD.0000000000000555","article-title":"Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy","volume":"29","author":"Abad-Fern\u00e1ndez","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bjid.2018.03.002","article-title":"Hepatitis C viral load in HCV-monoinfected and HCV\/HIV-1-, HCV\/HTLV-1\/-2-, and HCV\/HIV\/HTLV-1\/-2-co-infected patients from S\u00e3o Paulo, Brazil","volume":"22","author":"Alves","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/QAD.0000000000000208","article-title":"A closer look at hepatitis C clearance in HIV controllers: a response","volume":"28","author":"Asher","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/aid.2011.0342","article-title":"Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research","volume":"28","author":"Beilke","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.007_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8","article-title":"Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection","volume":"48","author":"Berger","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0035","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.virusres.2019.02.007_bib0040","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2016.06.039","article-title":"Multiple origins of virus persistence during natural control of HIV infection","volume":"166","author":"Boritz","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2019.02.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018726","article-title":"CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory","volume":"6","author":"Boufassa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077663","article-title":"Identification of a cluster of HIV-1 controllers infected with low replicating viruses","volume":"8","author":"Casado","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.007_bib0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1590\/0074-02760170307","article-title":"Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in patients with viral hepatitis B and C in Brazil","volume":"113","author":"Caterino-de-Araujo","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz, Rio de Janeiro"},{"key":"10.1016\/j.virusres.2019.02.007_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jmv.20336","article-title":"Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London","volume":"76","author":"Cooke","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/ciw120","article-title":"Analysis of non-AIDS-defining events in HIV controllers","volume":"62","author":"Dom\u00ednguez-Molina","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/ciw833","article-title":"HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers","volume":"64","author":"Dom\u00ednguez-Molina","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/jvi.70.3.1481-1492.1996","article-title":"Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2","volume":"70","author":"Eiraku","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.007_bib0085","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/hep.20938","article-title":"Hepatitis C virus load and survival among injection drug users in the United States","volume":"42","author":"Hisada","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.007_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/524143","article-title":"Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy","volume":"197","author":"Hunt","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12985-017-0797-2","article-title":"Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV\/HCV co-infected illicit drug users","volume":"14","author":"Jamalidoust","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2019.02.007_bib0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/433188","article-title":"HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication","volume":"41","author":"Lambotte","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/QAD.0000000000001050","article-title":"Rate and predictors of progression in elite and viremic HIV-1 controllers","volume":"30","author":"Le\u00f3n","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0110","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/01.aids.0000431945.72365.01","article-title":"Natural history of HIV-control since seroconversion","volume":"27","author":"Madec","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1089\/aid.2013.0014","article-title":"HTLV type 2a strains among HIV-1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians","volume":"29","author":"Magri","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.007_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jhep.2013.04.007","article-title":"Treatment optimization and prediction of HCV clearance in patients with acute HCV infection","volume":"59","author":"Mangia","year":"2013","journal-title":"J. Hepatology"},{"key":"10.1016\/j.virusres.2019.02.007_bib0125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/17474124.2015.1016914","article-title":"Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study)","volume":"9","author":"Marcellin","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2016.04.012","article-title":"Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: implications for the HTLV lifecycles","volume":"494","author":"Murphy","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2019.02.007_bib0135","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1128\/JVI.00548-10","article-title":"Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus","volume":"84","author":"O\u2019Connell","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/COH.0b013e328344f35e","article-title":"Epidemiology and clinical characteristics of elite controllers","volume":"6","author":"Okulicz","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1086\/646609","article-title":"Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study","volume":"200","author":"Okulicz","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fmicb.2013.00372","article-title":"HTLV-1\/-2 and HIV-1 co-infections: retroviral interference on host immune status","volume":"4","author":"Pilotti","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0155","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/QAD.0000000000001049","article-title":"Immunologic profiles distinguish aviremic HIV-infected adults","volume":"30","author":"Ramirez","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fmicb.2013.00271","article-title":"Highlights on distinctive structural and functional properties of HTLV Tax proteins","volume":"4","author":"Romanelli","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052467","article-title":"Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains","volume":"7","author":"Rong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.007_bib0170","first-page":"144","article-title":"The epidemiology and disease outcomes of HTLV-2","volume":"61","author":"Roucoux","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.007_bib0175","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1111\/j.1365-2893.2010.01431.x","article-title":"Hepatitis C virus replication in Caucasian HIV controllers","volume":"18","author":"Ruiz-Mateos","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2019.02.007_bib0180","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","article-title":"Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses","volume":"182","author":"S\u00e1ez-Ciri\u00f3n","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2019.02.007_bib0185","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0b013e32833a2a32","article-title":"Hepatitis C infection in HIV-1 natural viral suppressors","volume":"24","author":"Sajidi","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2019.02.007_bib0190","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198","author":"Soriano","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.007_bib0195","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Carrington M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.007_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1743-422X-9-71","article-title":"Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain","volume":"9","author":"Trevi\u00f1o","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2019.02.007_bib0205","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1128\/JVI.00056-12","article-title":"HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term","volume":"86","author":"Vingert","year":"2012","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218306944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218306944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:06:48Z","timestamp":1759154808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218306944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"alternative-id":["S0168170218306944"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2019.02.007","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}